Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Katherine Phoenix Liao, M.D.

Co-Author

This page shows the publications co-authored by Katherine Liao and Daniel Solomon.
Connection Strength

6.298
  1. Lipids and Cardiovascular Risk Through the Lens of Rheumatoid Arthritis. Arthritis Rheumatol. 2019 09; 71(9):1393-1395.
    View in: PubMed
    Score: 0.826
  2. Editorial: inflammation, disease-modifying antirheumatic drugs, lipids, and cardiovascular risk in rheumatoid arthritis. Arthritis Rheumatol. 2015 Feb; 67(2):327-9.
    View in: PubMed
    Score: 0.606
  3. Mechanistic insights into the link between inflammation and cardiovascular disease: rheumatoid arthritis as a human model of inflammation. Circ Cardiovasc Imaging. 2014 Jul; 7(4):575-7.
    View in: PubMed
    Score: 0.582
  4. Traditional cardiovascular risk factors, inflammation and cardiovascular risk in rheumatoid arthritis. Rheumatology (Oxford). 2013 Jan; 52(1):45-52.
    View in: PubMed
    Score: 0.514
  5. The end of rheumatoid factor as we know it? Arthritis Rheum. 2011 May; 63(5):1170-2.
    View in: PubMed
    Score: 0.467
  6. Clinical predictors of erosion-free status in rheumatoid arthritis: a prospective cohort study. Rheumatology (Oxford). 2011 Aug; 50(8):1473-9.
    View in: PubMed
    Score: 0.464
  7. The Association Between Inflammation, Incident Heart Failure, and Heart Failure Subtypes in Patients with Rheumatoid Arthritis. Arthritis Care Res (Hoboken). 2021 Oct 08.
    View in: PubMed
    Score: 0.241
  8. Classifying Pseudogout Using Machine Learning Approaches With Electronic Health Record Data. Arthritis Care Res (Hoboken). 2021 03; 73(3):442-448.
    View in: PubMed
    Score: 0.231
  9. Incorporating natural language processing to improve classification of axial spondyloarthritis using electronic health records. Rheumatology (Oxford). 2020 05 01; 59(5):1059-1065.
    View in: PubMed
    Score: 0.218
  10. Comparison of comorbidities and treatment between ankylosing spondylitis and non-radiographic axial spondyloarthritis in the United States. Rheumatology (Oxford). 2019 11 01; 58(11):2025-2030.
    View in: PubMed
    Score: 0.211
  11. Correction to: Association between inflammation and systolic blood pressure in RA compared to patients without RA. Arthritis Res Ther. 2019 Jul 08; 21(1):170.
    View in: PubMed
    Score: 0.206
  12. Impact of Changes in Inflammation on Estimated Ten-Year Cardiovascular Risk in Rheumatoid Arthritis. Arthritis Rheumatol. 2018 09; 70(9):1392-1398.
    View in: PubMed
    Score: 0.193
  13. Association between inflammation and systolic blood pressure in RA compared to patients without RA. Arthritis Res Ther. 2018 06 01; 20(1):107.
    View in: PubMed
    Score: 0.191
  14. Pseudogout among Patients Fulfilling a Billing Code Algorithm for Calcium Pyrophosphate Deposition Disease. Rheumatol Int. 2018 Jun; 38(6):1083-1088.
    View in: PubMed
    Score: 0.189
  15. Comparison of cardiovascular risk algorithms in patients with vs without rheumatoid arthritis and the role of C-reactive protein in predicting cardiovascular outcomes in rheumatoid arthritis. Rheumatology (Oxford). 2017 05 01; 56(5):777-786.
    View in: PubMed
    Score: 0.177
  16. Traditional Cardiovascular Disease Risk Factor Management in Rheumatoid Arthritis Compared to Matched Nonrheumatoid Arthritis in a US Managed Care Setting. Arthritis Care Res (Hoboken). 2016 05; 68(5):629-37.
    View in: PubMed
    Score: 0.165
  17. Cardiovascular risk factor management in patients with RA compared to matched non-RA patients. Rheumatology (Oxford). 2016 May; 55(5):809-16.
    View in: PubMed
    Score: 0.161
  18. Association between lipid levels and major adverse cardiovascular events in rheumatoid arthritis compared to non-rheumatoid arthritis patients. Arthritis Rheumatol. 2015 May; 67(8):2004-10.
    View in: PubMed
    Score: 0.154
  19. Lipid and lipoprotein levels and trend in rheumatoid arthritis compared to the general population. Arthritis Care Res (Hoboken). 2013 Dec; 65(12):2046-50.
    View in: PubMed
    Score: 0.140
  20. Testing the Effects of Disease-Modifying Antirheumatic Drugs on Vascular Inflammation in Rheumatoid Arthritis: Rationale and Design of the TARGET Trial. ACR Open Rheumatol. 2021 Jun; 3(6):371-380.
    View in: PubMed
    Score: 0.058
  21. Validation of a Bioassay for Predicting Response to Tumor Necrosis Factor Inhibitors in Rheumatoid Arthritis. Arthritis Rheumatol. 2021 06; 73(6):1086-1087.
    View in: PubMed
    Score: 0.058
  22. Performance of the Expanded Cardiovascular Risk Prediction Score for Rheumatoid Arthritis in a geographically distant National Register-based cohort: an external validation. RMD Open. 2018; 4(2):e000771.
    View in: PubMed
    Score: 0.050
  23. Cardiovascular Outcomes Associated with Lowering Low-density Lipoprotein Cholesterol in Rheumatoid Arthritis and Matched Nonrheumatoid Arthritis. J Rheumatol. 2016 11; 43(11):1989-1996.
    View in: PubMed
    Score: 0.042
  24. Rheumatoid Arthritis and Mortality Among Women During 36 Years of Prospective Follow-Up: Results From the Nurses' Health Study. Arthritis Care Res (Hoboken). 2016 06; 68(6):753-62.
    View in: PubMed
    Score: 0.042
  25. Tumor Necrosis Factor-a Inhibitor Use and the Risk of Incident Hypertension in Patients with Rheumatoid Arthritis. Epidemiology. 2016 May; 27(3):414-22.
    View in: PubMed
    Score: 0.041
  26. Disease-modifying antirheumatic drug use and the risk of incident hyperlipidemia in patients with early rheumatoid arthritis: a retrospective cohort study. Arthritis Care Res (Hoboken). 2015 Apr; 67(4):457-66.
    View in: PubMed
    Score: 0.038
  27. Rheumatoid arthritis and cardiovascular disease. Am Heart J. 2013 Oct; 166(4):622-628.e1.
    View in: PubMed
    Score: 0.034
Connection Strength
The connection strength for co-authors is the sum of the scores for each of their shared publications.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.